Jardiance DUO 12.5/850MG (60’s)

Login to view price


Empagliflozin/Metformin hydrochloride

JARDIANCE DUO is indicated as an adjunct to diet and exercise to improve glycaemic control in adult patients with type 2 diabetes mellitus: when treatment with both empagliflozin and metformin is appropriate (see Pharmacology: Pharmacodynamics: Clinical Trials under Actions and Dosage & Administration).
Inadequately controlled with metformin or empagliflozin alone.
Inadequately controlled with empagliflozin or metformin in combination with other glucose- lowering products including insulin.

Prevention of cardiovascular events: Empagliflozin is indicated in adults with type 2 diabetes mellitus and established cardiovascular disease to reduce the risk of cardiovascular death (see Pharmacology: Pharmacodynamics: Clinical Trials under Actions).

Dosage/Direction for Use
Adults with normal renal function (GFR ≥ 90ml/min): The recommended dose is one JARDIANCE DUO tablet twice daily.
The dosage should be individualised on the basis of the patient’s current regimen, effectiveness, and tolerability. The maximum recommended daily dose of JARDIANCE DUO is 25 mg of empagliflozin and 2000 mg of metformin.
Treatment naïve patients: The recommended starting dose is 5 mg/500 mg twice daily. If additional glycaemic control is required, adjust dosing based on effectiveness and tolerability while not exceeding the maximum recommended daily dose of 25 mg empagliflozin and 2000 mg metformin.
*The product images shown are for illustration purposes only and may not be an exact representation of the product.